|
IDH2-DT expression profile based on
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Stage1-vs-Stage2 |
N/A |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
N/A |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
N/A |
| Stage3-vs-Stage4 |
N/A |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Caucasian-vs-AfricanAmerican |
N/A |
| Caucasian-vs-Asian |
<1E-12 |
| AfricanAmerican-vs-Asian |
<1E-12 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Male-vs-Female |
N/A |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.247403E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.250113E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.277206E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
N/A |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.482786E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.751057E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Biphasic-vs-Epithelioid |
N/A |
| Biphasic-vs-Diffuse malignant |
N/A |
| Biphasic-vs-Sarcomatoid |
9.260623E-04 |
| Epithelioid-vs-Diffuse malignant |
N/A |
| Epithelioid-vs-Sarcomatoid |
6.735494E-03 |
| Diffuse malignant-vs-Sarcomatoid |
2.276530E-01 |
|
|